Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66 studies found for:    "Encephalitis, Japanese"
Show Display Options
Rank Status Study
21 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
22 Completed
Has Results
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
23 Completed
Has Results
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: Japanese Encephalitis purified inactivated vaccine (IC51);   Biological: Placebo
24 Completed
Has Results
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
25 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
26 Completed
Has Results
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX
27 Completed
Has Results
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
28 Completed
Has Results
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
29 Completed
Has Results
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
30 Completed
Has Results
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
31 Unknown  Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
32 Completed Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
33 Completed
Has Results
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE;   Biological: JE-VAX®
34 Completed
Has Results
Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects
Conditions: Rabies;   Japanese Encephalitis
Interventions: Biological: Rabies;   Biological: Japanese Encephalitis;   Other: Placebo
35 Recruiting Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj
Condition: Japanese Encephalitis
Intervention: Biological: Inactivated Japanese encephalitis vaccine (Beijing-Handai strain, cell-cultured)
36 Completed Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers
Conditions: Rabies;   Japanese Encephalitis;   Pre-Exposure Prophylaxis
Interventions: Biological: Three 1 mL doses of Rabies vaccine and two JE vaccine;   Biological: Three 0.5 mL doses of Rabies vaccine and two JE vaccine;   Biological: Three 0.1mL doses of Rabies Vaccine and two JE vaccine;   Biological: Two 0.1mL doses of Rabies vaccine and two JE vaccine;   Biological: Two doses of JE vaccine
37 Withdrawn Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination
Condition: Japanese Encephalitis
Intervention: Biological: IXIARO
38 Completed Study of a Booster Dose of IMOJEV® Vaccine One Year After Primary Immunization in Healthy Children in South Korea
Condition: Japanese Encephalitis
Intervention: Biological: IMOJEV®: Live Attenuated Japanese Encephalitis Chimeric Virus
39 Completed
Has Results
Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine
Condition: Japanese Encephalitis
Interventions: Biological: Live attenuated Japanese encephalitis virus;   Biological: ChimeriVax™ diluent (Placebo)
40 Completed
Has Results
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: ChimeriVax-JE, Japanese Encephalitis vaccine;   Biological: 0.9% Saline

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years